avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hbp1 | mm10_v2_chr12_-_31950535_31950560 | 0.21 | 2.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_127898515 Show fit | 13.34 |
ENSMUST00000047134.7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
|
chr5_-_86926521 Show fit | 12.21 |
ENSMUST00000031183.2
|
UDP glucuronosyltransferase 2 family, polypeptide B1 |
|
chr19_+_39992424 Show fit | 11.12 |
ENSMUST00000049178.2
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
|
chr19_-_8131982 Show fit | 10.28 |
ENSMUST00000065651.4
|
solute carrier family 22, member 28 |
|
chr12_-_104153846 Show fit | 10.04 |
ENSMUST00000085050.3
|
serine (or cysteine) peptidase inhibitor, clade A, member 3C |
|
chr19_+_39007019 Show fit | 9.41 |
ENSMUST00000025966.4
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
|
chr17_-_32917320 Show fit | 8.58 |
ENSMUST00000179434.1
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
|
chr19_+_39287074 Show fit | 8.36 |
ENSMUST00000003137.8
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
|
chr5_-_87337165 Show fit | 7.93 |
ENSMUST00000031195.2
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
|
chr4_-_115496129 Show fit | 7.37 |
ENSMUST00000030487.2
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 35.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
2.1 | 21.4 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
5.5 | 16.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.2 | 16.3 | GO:0015747 | urate transport(GO:0015747) |
0.9 | 13.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 10.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
3.0 | 9.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
2.2 | 8.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.0 | 7.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 7.9 | GO:0007586 | digestion(GO:0007586) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 94.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 21.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 13.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 8.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 7.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 6.7 | GO:0014069 | postsynaptic density(GO:0014069) |
0.6 | 6.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 6.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.7 | 5.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 4.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 60.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.0 | 23.8 | GO:0070330 | aromatase activity(GO:0070330) |
1.2 | 17.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 15.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
2.8 | 14.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 12.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 10.4 | GO:0008483 | transaminase activity(GO:0008483) |
2.5 | 10.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.4 | 9.4 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
1.3 | 9.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 4.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 4.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 4.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 3.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 3.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 3.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 2.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 22.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 16.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.1 | 14.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.6 | 13.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.8 | 6.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 6.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 5.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 5.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 5.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 4.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |